Optimising passive surveillance of a neglected tropical disease in the era of elimination: A modelling study

Background Surveillance is an essential component of global programs to eliminate infectious diseases and avert epidemics of (re-)emerging diseases. As the numbers of cases decline, costs of treatment and control diminish but those for surveillance remain high even after the ‘last’ case. Reducing surveillance may risk missing persistent or (re-)emerging foci of disease. Here, we use a simulation-based approach to determine the minimal number of passive surveillance sites required to ensure maximum coverage of a population at-risk (PAR) of an infectious disease. Methodology and Principal Findings For this study, we use Gambian human African trypanosomiasis (g-HAT) in north-western Uganda, a neglected tropical disease (NTD) which has been reduced to historically low levels (<1000 cases/year globally), as an example. To quantify travel time to diagnostic facilities, a proxy for surveillance coverage, we produced a high spatial-resolution resistance surface and performed cost-distance analyses. We simulated travel time for the PAR with different numbers (1-170) and locations (170,000 total placement combinations) of diagnostic facilities, quantifying the percentage of the PAR within 1h and 5h travel of the facilities, as per in-country targets. Our simulations indicate that a 70% reduction (51/170) in diagnostic centres still exceeded minimal targets of coverage even for remote populations, with >95% of a total PAR of ~3million individuals living ≤1h from a diagnostic centre, and we demonstrate an approach to best place these facilities, informing a minimal impact scale back. Conclusions Our results highlight that surveillance of g-HAT in north-western Uganda can be scaled back without reducing coverage of the PAR. The methodology described can contribute to cost-effective and equable strategies for the surveillance of NTDs and other infectious diseases approaching elimination or (re-)emergence. Author Summary Disease surveillance systems are an essential component of public health practice and are often considered the first line in averting epidemics for (re-)emerging diseases. Regular evaluation of surveillance systems ensures that they remain operating at maximum efficiency; systems that survey diseases of low incidence, such as those within elimination settings, should be simplified to reduce the reporting burden. A lack of guidance on how to optimise disease surveillance in an elimination setting may result in added expense, and/or the underreporting of disease. Here, we propose a framework methodology to determine systematically the optimal number and placement of surveillance sites for the surveillance of infectious diseases approaching elimination. By utilising estimates of geographic accessibility, through the construction of a resistance surface and a simulation approach, we identify that the number of operational diagnostic facilities for Gambian human African trypanosomiasis in north-western Uganda can be reduced by 70% without affecting existing coverage, and identify the minimum number of facilities required to meet coverage targets. Our analysis can be used to inform the number and positioning of surveillance sites for diseases within an elimination setting. Passive surveillance becomes increasingly important as cases decline and active surveillance becomes less cost-effective; methods to evaluate how best to engage this passive surveillance capacity given facility capacity and geographic distribution are pertinent for several NTDs where diagnosis is complex. Not only is this a complicated research area for diseases approaching elimination, a well-designed surveillance system is essential for the detection of emerging diseases, with this work being topical in a climate where emerging pathogens are becoming more commonplace.

[1]  J. Longbottom,et al.  Quantifying geographic accessibility to improve efficiency of entomological monitoring , 2020, PLoS neglected tropical diseases.

[2]  Panos M. Pardalos,et al.  Spatial Interaction Models , 2017 .

[3]  Peter M Atkinson,et al.  Spatial modelling of healthcare utilisation for treatment of fever in Namibia , 2012, International Journal of Health Geographics.

[4]  R. Steinglass,et al.  Impact of targeted programs on health systems: a case study of the polio eradication initiative. , 2002, American journal of public health.

[5]  V. Jamonneau,et al.  Gambian human African trypanosomiasis in North West Uganda. Are we on course for the 2020 target? , 2019, PLoS neglected tropical diseases.

[6]  V. Jamonneau,et al.  Improved Models of Mini Anion Exchange Centrifugation Technique (mAECT) and Modified Single Centrifugation (MSC) for Sleeping Sickness Diagnosis and Staging , 2009, PLoS neglected tropical diseases.

[7]  Justin Lessler,et al.  Quantifying the Risk and Cost of Active Monitoring for Infectious Diseases , 2017, Scientific Reports.

[8]  P. Sellers Canopy reflectance, photosynthesis and transpiration , 1985 .

[9]  T. V. Van Boeckel,et al.  Monitoring the impact of decentralised chronic care services on patient travel time in rural Africa - methods and results in Northern Malawi , 2012, International Journal of Health Geographics.

[10]  National, State, and Local Public Health Surveillance Systems , 2014 .

[11]  E. Matovu,et al.  Improved detection of Trypanosoma brucei by lysis of red blood cells, concentration and LED fluorescence microscopy. , 2012, Acta tropica.

[12]  P. Kennedy Clinical features, diagnosis, and treatment of human African trypanosomiasis (sleeping sickness) , 2013, The Lancet Neurology.

[13]  G. Cecchi,et al.  Monitoring the elimination of human African trypanosomiasis: Update to 2014 , 2017, PLoS neglected tropical diseases.

[14]  D. Henderson Surveillance of smallpox. , 1976, International journal of epidemiology.

[15]  T. Rebbeck,et al.  Geospatial evaluation of trade-offs between equity in physical access to healthcare and health systems efficiency , 2020, BMJ Global Health.

[16]  Ranga B. Myneni,et al.  The interpretation of spectral vegetation indexes , 1995, IEEE Transactions on Geoscience and Remote Sensing.

[17]  Joshua Longbottom,et al.  Quantifying geographic accessibility to improve cost-effectiveness of entomological monitoring , 2019 .

[18]  Robert C Hornik,et al.  Use of mass media campaigns to change health behaviour , 2010, The Lancet.

[19]  L. Lee,et al.  Updated guidelines for evaluating public health surveillance systems: recommendations from the Guidelines Working Group. , 2001, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.

[20]  F. Checchi,et al.  Estimates of the duration of the early and late stage of gambiense sleeping sickness , 2008, BMC infectious diseases.

[21]  S. Torr,et al.  Tsetse Control and Gambian Sleeping Sickness; Implications for Control Strategy , 2015, PLoS neglected tropical diseases.

[22]  Ronan A Lyons,et al.  Measuring performance on the Healthcare Access and Quality Index for 195 countries and territories and selected subnational locations: a systematic analysis from the Global Burden of Disease Study 2016 , 2018, The Lancet.

[23]  G. Cecchi,et al.  Mapping the capacities of fixed health facilities to cover people at risk of gambiense human African trypanosomiasis , 2014, International Journal of Health Geographics.

[24]  D. Molyneux,et al.  The elimination of Trypanosoma brucei gambiense? Challenges of reservoir hosts and transmission cycles: Expect the unexpected , 2019, Parasite epidemiology and control.

[25]  J. Longbottom,et al.  Trypa-NO! contributes to the elimination of gambiense human African trypanosomiasis by combining tsetse control with “screen, diagnose and treat” using innovative tools and strategies , 2020, PLoS neglected tropical diseases.

[26]  S. Galea,et al.  Community perceptions and factors influencing utilization of health services in Uganda , 2009 .

[27]  C. S. Sutherland,et al.  Is the elimination of ‘sleeping sickness’ affordable? Who will pay the price? Assessing the financial burden for the elimination of human African trypanosomiasis Trypanosoma brucei gambiense in sub-Saharan Africa , 2019, BMJ Global Health.

[28]  Peter J. Diggle,et al.  Inhibitory geostatistical designs for spatial prediction taking account of uncertain covariance structure , 2016, 1605.00104.

[29]  G. Cecchi,et al.  Monitoring the elimination of human African trypanosomiasis at continental and country level: Update to 2018 , 2020, PLoS neglected tropical diseases.

[30]  E. Matovu,et al.  Enhanced passive screening and diagnosis for gambiense human African trypanosomiasis in north-western Uganda – Moving towards elimination , 2017, PloS one.

[31]  P. Simarro,et al.  Epidemiology of human African trypanosomiasis , 2014, Clinical epidemiology.

[32]  Bernard C. K. Choi,et al.  The Past, Present, and Future of Public Health Surveillance , 2012, Scientifica.

[33]  Thomas R. Etherington,et al.  Least-Cost Modelling and Landscape Ecology: Concepts, Applications, and Opportunities , 2016 .

[34]  E. Fèvre,et al.  Estimating and Mapping the Population at Risk of Sleeping Sickness , 2012, PLoS neglected tropical diseases.

[35]  David L Buckeridge,et al.  Public Health Surveillance Systems: Recent Advances in Their Use and Evaluation. , 2017, Annual review of public health.

[36]  J. Palmer,et al.  Integrating innovations: a qualitative analysis of referral non-completion among rapid diagnostic test-positive patients in Uganda’s human African trypanosomiasis elimination programme , 2018, Infectious Diseases of Poverty.

[37]  W. Dowdle,et al.  Disease Eradication in the 21st Century , 2011 .

[38]  Jean C. O'Connor,et al.  The Legal Basis for Public Health Surveillance , 2014 .

[39]  Boniface Namangala,et al.  Direct Blood Dry LAMP: A Rapid, Stable, and Easy Diagnostic Tool for Human African Trypanosomiasis , 2015, PLoS neglected tropical diseases.

[40]  Marleen Boelaert,et al.  Sensitivity and Specificity of a Prototype Rapid Diagnostic Test for the Detection of Trypanosoma brucei gambiense Infection: A Multi-centric Prospective Study , 2016, PLoS neglected tropical diseases.

[41]  R. F. Goldman,et al.  Terrain coefficients for energy cost prediction. , 1972, Journal of applied physiology.

[42]  David H. Douglas Least-cost Path in GIS Using an Accumulated Cost Surface and Slopelines , 1994 .

[43]  P. Lutumba,et al.  Cost-effectiveness of using a rapid diagnostic test to screen for human African trypanosomiasis in the Democratic Republic of the Congo , 2018, PloS one.

[44]  S. Thacker,et al.  Planning a public health surveillance system. , 1995, Epidemiological bulletin.

[45]  F. Checchi,et al.  Prevalence and under-detection of gambiense human African trypanosomiasis during mass screening sessions in Uganda and Sudan , 2012, Parasites & Vectors.

[46]  M. Kruk,et al.  Factors influencing modes of transport and travel time for obstetric care: a mixed methods study in Zambia and Uganda. , 2016, Health policy and planning.

[47]  G. Cecchi,et al.  Monitoring the elimination of human African trypanosomiasis: Update to 2016 , 2018, PLoS neglected tropical diseases.